Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. May 16, 2021; 9(14): 3320-3326
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3320
Table 1 Clinical and pathological data of the patient
Project
Content
Biographical data33-yr-old man
Family historyNo
Personal or family history No
Chief complaintCough and sputum for 11 d and hemoptysis for 5 d
Physical examination of the lungNormal except for vesicular breath sounds
Chest computed tomography1.20 cm × 0.88 cm calcified nodular lesion was found on the compressed posterior wall of the lower left main bronchus (Figure 1). Bronchiectasis in the lower lobe of the left lung was found.
Fiberoptic bronchoscopyYellow–white, slightly hard mass was found obstructing the entrance to the basal segment of the lower left lobe (Figure 2). Neoplasms with multiple nodular ridges and superficial hyperemia were observed in the lateral to the entrance of the basal segment of the lower left lobe (Figure 2). Mucosal biopsy using a fiberoptic bronchoscopy is prone to bleeding.
PathologyMicroscopically, the tumor cells were uniformly round with smooth nuclear contours, fine chromatin and a modest amount of pink cytoplasm. They were arranged in sheet-like patterns between small blood vessels (Figure 3A). Left main bronchial glomus tumor with immunohistochemistry results of SMA(+) (Figure 3B) and actin(+) (Figure 3C), CD56 (NK-1)(-), CgA(-), CK5/6(-), CK7(-), napsin-A(-), P40(-), TTF-1(-), CK(-), NSE(-), S-100(-) and Ki-67 (< 1%), and Syn immunohistochemical staining was weakly positive.
Final diagnosisBronchial glomus tumor and bronchiectasis
TreatmentConservative treatment. Piperacillin–tazobactam 4.5 g twice daily and erdosteine 0.3 g twice daily for 9 d. Intravenous administration of Agkistrodon 2 U once.
Follow-upClinical follow-up for 25 mo showed that the patient had no symptoms.